This situation may be caused by previous studies reporting BC risk in populations selected on the grounds of having colorectal cancer, and usually these cohorts consisted only of MLH1 and MSH2 carriers (which account for approximately 90% of the PVs associated with colorectal cancer) and few MSH6 and PMS2 carriers [48,51]. Here, MSH2 is linked to colorectal cancer.